SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510964-23-000032
Filing Date
2023-08-14
Accepted
2023-08-14 16:21:25
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20230630.htm   iXBRL 10-Q 882970
2 EX-10.4 nog2023equityincentiveplan.htm EX-10.4 66997
3 EX-31.1 cvsi-2023630xex311.htm EX-31.1 9245
4 EX-31.2 cvsi-2023630xex312.htm EX-31.2 9221
5 EX-32.1 cvsi-2023630xex321.htm EX-32.1 4169
6 EX-32.2 cvsi-2023630xex322.htm EX-32.2 4138
  Complete submission text file 0001510964-23-000032.txt   5059985

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20230630.xsd EX-101.SCH 38540
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvsi-20230630_cal.xml EX-101.CAL 46800
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvsi-20230630_def.xml EX-101.DEF 174484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20230630_lab.xml EX-101.LAB 524007
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20230630_pre.xml EX-101.PRE 321467
57 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20230630_htm.xml XML 505317
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 231170639
SIC: 2834 Pharmaceutical Preparations